Zobrazeno 1 - 10
of 23
pro vyhledávání: '"J. L. Ascensao"'
Publikováno v:
Scopus-Elsevier
The aim of the study was to alleviate graft-versus-host reaction (GVHR) by pre-treatment of the bone marrow (BM) transplant with hydrocortisone (HC) and cyclosporin A (CsA) in C57BL/6J (donor) --> CBA/J (recipient) mouse combination. BM cells were ex
Autor:
J L Ascensao, Abraham Mittelman, Tauseef Ahmed, L. Helson, P. Cook, Robert A. Preti, R Kancherla, Morton Coleman, M Beer, Karen Seiter, T Akhtar, Eric J. Feldman, R Goldberg, D. E. Lake
Publikováno v:
Bone Marrow Transplantation. 19:449-454
To evaluate a strategy of one cycle of dose-intensive chemotherapy for patients with Hodgkin's disease in sensitive relapse and two cycles for those with refractory disease, 122 patients received dose-intensive chemotherapy followed by autotransplant
Publikováno v:
British Journal of Cancer
Roquinimex (Roq) is an immunomodulator known to stimulate cellular immune responses. It is currently used for immunotherapy after bone marrow transplantation (BMT). One of the major features of this compound is an enhancement of natural killer (NK) c
Publikováno v:
Blood. 83:370-376
In an effort to study whether human cytomegalovirus (HCMV) can disrupt the balanced cytokine network that controls human hematopoiesis, we investigated the ability of a laboratory strain HCMV (AD169) to alter the production of interleukin-6 (IL-6) by
Publikováno v:
Blood. 95(2)
Apart from congenital human cytomegalovirus (HCMV) infection, manifest HCMV disease occurs primarily in immunocompromised patients. In allogeneic bone marrow transplantation, HCMV is frequently associated with graft failure and cytopenias involving a
Publikováno v:
Experimental hematology. 22(11)
Publikováno v:
Blood. 84(3)
Human natural killer (NK) cells comprise 10% to 15% of peripheral blood mononuclear cells and have an important role in immune responses against tumors, viral infections, and graft rejection. NK cells originate in bone marrow (BM), but their progenit
Publikováno v:
Annals of clinical and laboratory science. 22(4)
A patient is presented who was treated with ablative therapy for Hodgkin's disease and rescued by reinfusion of peripheral blood stem cells (PBSC). The PBSC were used because previous therapy (chemotherapy and radiation to the pelvis) had resulted in
Publikováno v:
Bone marrow transplantation. 10
In the present work we used allogeneic in utero transplantation of fetal stem cells in sheep and monkeys. Thus, both the donor and recipient cells had preimmune status. We showed engraftment of allogeneic stem cells in the tolerant environment of the
Publikováno v:
Transactions of the Association of American Physicians. 105
Tissue distribution of HSC in fetal sheep was studied by in utero transplantation during the period when a switch in the site of hemopoiesis occurs from liver/spleen to the bone marrow. At day 50 of gestation, transplanted cells exclusively homed to